Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Adrien Bigot et al.|British Journal of Dermatology|2021Cited by 414
<i>UBA1</i> Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeÈve Zakine, Jean‐David Bouaziz, Bérénice Schell et al.|JAMA Dermatology|2021Cited by 120
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Laëtitia Largeaud et al.|Blood|2022Cited by 80
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaMarie Sébert, Éliane Gluckman, Stéphanie Gachet et al.|Cell stem cell|2023Cited by 75
Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune diseaseLin‐Pierre Zhao, Lionel Adès, Bérénice Schell et al.|Leukemia|2021Cited by 43